147 related articles for article (PubMed ID: 11888675)
1. Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo.
Um SJ; Rhyu JW; Kim EJ; Jeon KC; Hwang ES; Park JS
Cancer Lett; 2002 May; 179(2):205-12. PubMed ID: 11888675
[TBL] [Abstract][Full Text] [Related]
2. Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice.
Park JS; Rhyu JW; Kim CJ; Kim HS; Lee SY; Kwon YI; Namkoong SE; Sin HS; Um SJ
Gynecol Oncol; 2003 Jun; 89(3):360-8. PubMed ID: 12798696
[TBL] [Abstract][Full Text] [Related]
3. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis.
Park JS; Kim EJ; Kwon HJ; Hwang ES; Namkoong SE; Um SJ
J Biol Chem; 2000 Mar; 275(10):6764-9. PubMed ID: 10702232
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1.
Perea SE; Massimi P; Banks L
Int J Mol Med; 2000 Jun; 5(6):661-6. PubMed ID: 10812019
[TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression.
Lee SH; Kim JW; Lee HW; Cho YS; Oh SH; Kim YJ; Jung CH; Zhang W; Lee JH
Oncogene; 2003 Jan; 22(3):381-91. PubMed ID: 12545159
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-alpha.
Flowers CC; Flowers SP; Nabel GJ
Mol Med; 1998 Jun; 4(6):402-12. PubMed ID: 10780883
[TBL] [Abstract][Full Text] [Related]
8. Interaction between interferon regulatory factor-1 and human papillomavirus E7 oncogene in cervical cancer: an ontology study.
Wiwanitkit V
Taiwan J Obstet Gynecol; 2009 Jun; 48(2):138-41. PubMed ID: 19574175
[TBL] [Abstract][Full Text] [Related]
9. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burysek L; Yeow WS; Pitha PM
J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
[TBL] [Abstract][Full Text] [Related]
10. Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.
Jabbar SF; Abrams L; Glick A; Lambert PF
Cancer Res; 2009 May; 69(10):4407-14. PubMed ID: 19435895
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells.
Chen L; Wu YY; Liu P; Wang J; Wang G; Qin J; Zhou J; Zhu J
Med Oncol; 2011 Dec; 28 Suppl 1():S528-39. PubMed ID: 21222176
[TBL] [Abstract][Full Text] [Related]
12. Replacement of 198MQMDII203 of mouse IRF-1 by 197IPVEVV202 of human IRF-1 abrogates induction of IFN-beta, iNOS, and COX-2 gene expression by IRF-1.
Upreti M; Kumar S; Rath PC
Biochem Biophys Res Commun; 2004 Feb; 314(3):737-44. PubMed ID: 14741697
[TBL] [Abstract][Full Text] [Related]
13. Cervical/vaginal dysplasias of transgenic mice harbouring human papillomavirus type 16 E6-E7 genes.
Sasagawa T; Kondoh G; Inoue M; Yutsudo M; Hakura A
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3057-65. PubMed ID: 7964615
[TBL] [Abstract][Full Text] [Related]
14. Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variants in cervical cancer of Korean women.
Kim YB; Song YS; Jeon YT; Park JS; Um SJ; Kim JW; Park NH; Kang SB; Lee HP
Oncol Rep; 2005 Aug; 14(2):459-64. PubMed ID: 16012730
[TBL] [Abstract][Full Text] [Related]
15. Interferon-β induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells.
Zhang J; Li S; Yan Q; Chen X; Yang Y; Liu X; Wan X
PLoS One; 2013; 8(12):e81366. PubMed ID: 24358111
[TBL] [Abstract][Full Text] [Related]
16. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
17. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
18. The human papillomavirus type 16 E7 protein binds human interferon regulatory factor-9 via a novel PEST domain required for transformation.
Antonsson A; Payne E; Hengst K; McMillan NA
J Interferon Cytokine Res; 2006 Jul; 26(7):455-61. PubMed ID: 16800784
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
20. Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes.
Lace MJ; Anson JR; Haugen TH; Turek LP
Virology; 2010 Apr; 399(2):270-9. PubMed ID: 20129639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
